Skip to main content

Table 1 Demographic characteristics (ITT population)

From: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

Variable

Darbepoetin alfa (N = 63)

Erythropoietin alfa (N = 63)

Overall (N = 126)

Age (years)

 Mean (SD)

44.8 (11.81)

48.8 (12.60)

46.8 (12.32)

 Median (range)

47.0 (21, 65)

51.0 (21, 65)

49.0 (21, 65)

Height (cm)

 Mean (SD)

158.6 (11.31)

159.5 (22.27)

159.1 (17.60)

 Median (range)

160.0 (127, 178)

163.0 (5.5, 182)

160.0 (5.5, 182)

Weight (kg)

 Mean (SD)

58.93 (15.30)

58.74 (11.92)

58.84 (13.66)

 Median (range)

56.50 (34, 95)

60.00 (38.5, 88)

57.50 (34, 95)

Gender, n (%)

 Male

39 (61.90)

46 (73.02)

85 (67.46)

 Female

24 (38.10)

17 (26.98)

41 (32.54)

  1. n number of subject at each visit; N total number of subjects, ITT Intent to treat